On September 8, 2023, Edward Jordan informed Humanigen, Inc. of his resignation from his position as Chief Commercial Officer of the Company, effective September 14, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | +100.00% | -50.00% | -83.33% |
Apr. 12 | Combined Liquidation Plan and Disclosure Statement Filed by Humanigen, Inc. | CI |
Mar. 08 | Final DIP Financing Approved for Humanigen, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
-83.33% | 11.91K | |
-3.05% | 90.45B | |
+3.68% | 41.45B | |
-10.96% | 33.57B | |
+59.95% | 25.73B | |
-20.20% | 14.73B | |
-8.93% | 12.82B | |
-11.46% | 11.7B | |
-43.53% | 11.44B | |
+4.87% | 8.79B |
- Stock Market
- Equities
- HGENQ Stock
- News Humanigen, Inc.
- Humanigen, Inc. Announces Resignation of Edward Jordan as Chief Commercial Officer